jueves, 13 de marzo de 2025

Fosdenopterin (Nulibry) Use of a Single Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence to Demonstrate Substantial Evidence of Effectiveness for a Rare Disease

https://www.fda.gov/media/185752/download?attachment=&utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario